FDA revises labels, recommends limiting simvastatin dosing – ModernMedicine

FDA revises labels, recommends limiting simvastatin dosing ModernMedicine FDA recommendation follows a review of the results of the 7-year Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine clinical trial, other clinical trial data, and an analysis of data from the agency's Adverse Event ... Read more »